Megamonas

Overview

Megamonas is a genus of obligate anaerobic, Gram-negative bacteria in the family Veillonellaceae (class Negativicutes, phylum Firmicutes). The type species is Megamonas hypermegale, with M. funiformis also well-characterized. It is a common member of the human gut microbiota — particularly abundant in Asian populations — and is a significant carbohydrate fermenter producing propionate and valerate as primary short-chain fatty acid end-products he 2023 altered gut microbiota scfa constipated asd chinese.

What makes Megamonas notable in the WikiBiome context is its contradictory directionality across conditions: enriched in some diseases, depleted in others, with no simple "good vs. bad" classification. This context-dependence makes it a useful marker for understanding disease-specific ecological shifts rather than a universal indicator of health or dysbiosis.

SCFA Production Profile

Unlike the dominant butyrate producers (faecalibacterium prausnitzii, roseburia), Megamonas primarily produces propionate and valerate:

• Enrichment in constipated ASD children was associated with elevated propionate levels he 2023 altered gut microbiota scfa constipated asd chinese.
• Enrichment in ASD more broadly was associated with elevated valeric acid liu 2019 altered gut microbiota scfa chinese children asd.
• M. funiformis emerged as an indicator of healthier dietary patterns in ASD children, suggesting its metabolic role may be diet-dependent wu 2025 distinct diet microbiome associations asd.

The propionate connection is significant — propionic acid at elevated concentrations has been linked to ASD-like behavioral changes in animal models, while at normal concentrations it supports colonocyte health and immune regulation. The dose-response and context may determine whether Megamonas enrichment is beneficial or pathological.

Conditions Associated

Enriched

• Autism spectrum disorder (4 independent studies): Consistently overrepresented in ASD children across Chinese cohorts. Associated with elevated valeric acid liu 2019 altered gut microbiota scfa chinese children asd and elevated propionate in constipated ASD he 2023 altered gut microbiota scfa constipated asd chinese. Functional profiling associates with SCFA production and metabolic alterations deng 2022 gi symptoms minor impact asd microbiota scfa. However, M. funiformis was also an indicator of healthier diet patterns in ASD, complicating the pathological narrative wu 2025 distinct diet microbiome associations asd.
• Hashimoto's thyroiditis: Increased alongside decreased Bifidobacterium and Klebsiella, part of a consistent HT dysbiosis pattern mendoza leon 2023 scfas thyroid function. Significant genus-level differences with gender-specific and hormone-regulated patterns liu 2022 gut microbiota diversity hashimotos.
• Prostate cancer: Men with high serum testosterone (>455 ng/dL) showed increased Megamonas (r=0.46, p=0.009), suggesting a testosterone-microbiome axis trecarten 2025 obesity diet microbiome prostate cancer.

Depleted

• Graves' disease: Both GD and HT groups had lower Megamonas vs. healthy controls (Kruskal-Wallis significant) zhao 2022 gut microbiota graves disease hashimotos. Consistent reduction across thyroid diseases fang 2024 gut microbiota thyroid disease advances.
• Thyroid cancer: Decreased alongside Roseburia and Bacteroides wang 2025 gut microbiome thyroid cancer review fang 2024 gut microbiota thyroid disease advances.
• Heart failure: Depleted in both decompensated and compensated HF vs. controls (P<0.001) hayashi 2019 gut microbiome metabolites heart failure.
• Colorectal adenoma/cancer: Healthy microbiome characterized by preponderance of Megamonas and Sphingobium; depleted in adenoma and CRC progression saito 2019 metagenomic gut microbiota colorectal adenoma.

Other Associations

• Schizophrenia: Listed as a dominant genus in schizophrenia patients alongside Faecalibacterium, Ruminococcus, and Akkermansia li 2021 gut microbiome brain structure function schizophrenia.
• Chronic kidney disease: Abundance positively correlated with cognitive performance (attention, executive function) in hemodialysis patients gao 2024 intestinal flora cognitive function hemodialysis.
• Male reproductive function: Implicated in reproductive dysfunction signatures lv 2024 gut microbiota male reproductive function review.

The Thyroid Paradox

The most striking pattern is the contradictory directionality within thyroid diseases: Megamonas is enriched in Hashimoto's thyroiditis but depleted in Graves' disease and thyroid cancer. Both are autoimmune thyroid conditions with distinct immunological mechanisms (Th1-dominant destruction in HT vs. stimulatory autoantibodies in GD). The divergent Megamonas patterns may reflect:

1. Different immune environments selecting for different ecological niches — HT's chronic destruction may create conditions favoring Megamonas carbohydrate fermentation, while GD's stimulatory state does not.
2. Hormonal influence — thyroid hormone levels differ dramatically (hypothyroid in HT, hyperthyroid in GD), and Megamonas shows gender-specific and hormone-regulated patterns liu 2022 gut microbiota diversity hashimotos.
3. The testosterone connection — the prostate cancer finding (Megamonas correlated with testosterone, r=0.46) trecarten 2025 obesity diet microbiome prostate cancer suggests hormonal regulation of this genus, which could explain thyroid hormone-dependent shifts.

This contradiction needs resolution by future studies measuring Megamonas alongside thyroid hormone panels and immune markers simultaneously.

Ecological Role

Megamonas occupies a specific niche as an obligate anaerobe fermenting complex carbohydrates to propionate and valerate. Its depletion in heart failure, CRC, and thyroid cancer — and its association with cognitive function in CKD and healthy diet patterns in ASD — suggests that under normal conditions it contributes to a healthy fermentative ecosystem. Its enrichment in ASD and HT may reflect compensatory overgrowth when other fermenters are displaced, or it may directly contribute to pathology through excess propionate production.

Cross-References

• propionic acid — primary SCFA product; excess linked to ASD-like behavior in animal models
• short chain fatty acids — Megamonas as propionate/valerate producer
• autism spectrum disorder — enriched across 4 independent studies
• hashimotos thyroiditis — enriched; contradicts depletion in Graves'
• graves disease — depleted; thyroid paradox
• heart failure — depleted (P<0.001)
• colorectal cancer — depleted; healthy marker in adenoma progression
• schizophrenia — dominant genus in patients
• gut brain axis — cognitive correlation in CKD, ASD enrichment